Health Policy
WHO guidelines, EU directives, and Georgian health governance
Biotech Industry Faces Political Uncertainty and AI Profitability Questions at BIO 2026
Biotech executives at BIO 2026 confronted mounting concerns over Chinese competition, the uncertain profitability of AI-driven drug discovery, and political…
Editor's Top Picks
Eli Lilly’s Obesity Drug Access: What We Know About FDA Approval Pathways
Regulatory pathways and corporate strategy shape early access to obesity drug candidates. Pharmaceutical acquisitions in the metabolic disease sector reflect…
Submit Your Paper →
More form Health Policy
Asia-Pacific cardiovascular care lags in access and equity, systematic review finds
A systematic review in The Lancet Regional Health – Western Pacific identifies substantial disparities in…
Can Biomarker Testing Reduce Unnecessary Antibiotics in Primary Care?
Biomarker-guided testing could reduce unnecessary antibiotic prescribing in primary care, particularly for viral respiratory infections.…
South Asian climate-health research faces representation gap: who funds and controls the knowledge?
South Asia faces severe climate-health impacts yet remains underrepresented in global research leadership and funding.…
WHO releases first comprehensive clinical guidelines for Ebola and Marburg virus management
The World Health Organization has released its first unified clinical management guidelines for filovirus diseases,…
Europe tightens avian flu surveillance as H5N1 spreads among wild birds
The European Centre for Disease Prevention and Control has released unified surveillance guidelines for avian…